华北制药腺苷钴胺胶囊获得药品注册证书

Core Viewpoint - North China Pharmaceutical has received the drug registration certificate for Adenosylcobalamin capsules (0.5mg) from the National Medical Products Administration, indicating a significant regulatory approval for the company’s product line [1] Group 1: Company Developments - The company announced the approval of Adenosylcobalamin capsules, which are primarily used for the prevention and treatment of Vitamin B12 deficiency [1] - The product is also indicated for supplementation when dietary intake of Vitamin B12 is insufficient and for treating megaloblastic anemia [1]